Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSOxyberberine is an alkaloid and a metabolite of the alkaloid berberine (Item No. 10006427) that has been found in A. mexicana and has diverse biological activities.1,2,3 Oxyberberine is formed from berberine by gut microbiota.2 It reduces viability of SW480 colon cancer cells when used at concentrations ranging from 1 to 200 µg/ml.1 Oxyberberine (50 and 100 mg/kg) increases the ratio of phosphorylated to unphosphorylated PI3K, Akt, and GSK3β in isolated rat pancreatic tissue and reduces rat blood glucose levels in an oral glucose tolerance test in a model of diabetes induced by streptozotocin (STZ; Item No. 13104).2 It also reduces inflammation and hepatosteatosis in a rat model of high-fat diet-induced non-alcoholic fatty liver disease (NAFLD).3
WARNING This product is not for human or veterinary use.
1. Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line. Pharm. Biol. 54(4), 740-745 (2016).
2. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways. Biomed. Pharmacother. 137, 111312 (2021).
3. Therapeutic effect of oxyberberine on obese non-